Current epidemiology of hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Survey

Hepatology

Volumn 60, Issue 3, 2014, Pages 815-822

  Ditah, Ivo ^a   Ditah, Fausta ^b   Devaki, Pardha ^c   Ditah, Calistus ^d   Kamath, Patrick S ^a   Charlton, Michael ^e  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; DEMOGRAPHY; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EPIDEMIOLOGY; FEMALE; HEPATITIS A; HEPATITIS C; HEPATITIS E; HEPATITIS E VIRUS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAT; MEDICAL SOCIETY; POPULATION; PRIORITY JOURNAL; RACE; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SOCIAL STATUS; UNITED STATES; WATER SUPPLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEPATITIS E; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREGNANCY; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84906512308     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27219     Document Type: Article

References (56)

1. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012;379:2477-2488.
2. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503.
3. Bile K, Isse A, Mohamud O, Allebeck P, Nilsson L, Norder H, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994;51:466-474.
4. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992;70:597-604.
5. Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, Kamili S, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis 2010;16:126-129.
6. Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991;26(Suppl 3):135-138.
7. Sharapov MB, Favorov MO, Yashina TL, Brown MS, Onischenko GG, Margolis HS, et al. Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data. BMC Infect Dis 2009;9:35.
8. Tsega E, Hansson BG, Krawczynski K, Nordenfelt E. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis 1992;14:961-965.
9. Tsega E, Krawczynski K, Hansson BG, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993;31:173-181.
10. Schwartz E, Jenks NP, Van DP, Galun E. Hepatitis E virus infection in travelers. Clin Infect Dis 1999;29:1312-1314.
11. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
12. Chapman BA, Burt MJ, Wilkinson ID, Schousboe MI. Community acquired viral hepatitis in New Zealand: a case of sporadic hepatitis E virus infection. Aust N Z J Med 1993;23:722-723.
13. Heath TC, Burrow JN, Currie BJ, Bowden FJ, Fisher DA, Demediuk BH, et al. Locally acquired hepatitis E in the Northern Territory of Australia. Med J Aust 1995;162:318-319.
14. Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005;192:1166-1172.
15. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419-424.
16. Sainokami S, Abe K, Kumagai I, Miyasaka A, Endo R, Takikawa Y, et al. Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J Gastroenterol 2004;39:640-648.
17. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007;45:2009-2010.
18. Buti M, Dominguez A, Plans P, Jardi R, Schaper M, Espunes J, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006;13:1328-1332.
19. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008;20:784-790.
20. Ding X, Li TC, Hayashi S, Masaki N, Tran TH, Hirano M, et al. Present state of hepatitis E virus epidemiology in Tokyo, Japan. Hepatol Res 2003;27:169-173.
21. Lewis HC, Wichmann O, Duizer E. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 2010;138:145-166.
22. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008;80:289-293.
23. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35:1244-1247.
24. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009;200:48-56.
25. Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, et al. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 2006;12:1682-1688.
26. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008;80:289-293.
27. Tanaka E, Matsumoto A, Takeda N, Li TC, Umemura T, Yoshizawa K, et al. Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan. J Viral Hepat 2005;12:439-442.
28. Buisson Y, Grandadam M, Nicand E, Cheval P, van Cuyck-Gandre H, Innis B, et al. Identification of a novel hepatitis E virus in Nigeria. J Gen Virol 2000;81(Pt 4):903-909.
29. van Cuyck-Gandre H, Zhang HY, Tsarev SA, Clements NJ, Cohen SJ, Caudill JD, et al. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. J Med Virol 1997;53:340-347.
30. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120-131.
31. Meng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011;161:23-30.
32. Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011;108:2438-2443.
33. Takahashi H, Tanaka T, Jirintai S, Nagashima S, Takahashi M, Nishizawa T, et al. A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food. Arch Virol 2012;157:235-246.
34. Zhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009;81:1371-1379.
35. Tang X, Yang C, Gu Y, Song C, Zhang X, Wang Y, et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc Natl Acad Sci U S A 2011;108:10266-10271.
36. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805.
37. Ghabrah TM, Tsarev S, Yarbough PO, Emerson SU, Strickland GT, Purcell RH. Comparison of tests for antibody to hepatitis E virus. J Med Virol 1998;55:134-137.
38. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998;27:857-861.
39. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007;14:562-568.
40. Centers for Disease Control. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/HEPE_F_met_IgG_antibody.pdf. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, 2012.
41. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey (NHANES) Available at: www.cdc.gov/nchs/about/major/nhanes/intro_mec.htm. Accessed May 13, 2013. N/A 2009.
42. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013;19:218-222.
43. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey (NHANES). 2009.
44. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012;367:1237-1244.
45. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007;26:1429-1435.
46. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;141:1665-1672.
47. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013;207:497-500.
48. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, Dimitrova Z, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010;51:e24-e27.
49. Khuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet 1993;341:1355.
50. Myint KS, Endy TP, Shrestha MP, Shrestha SK, Vaughn DW, Innis BL, et al. Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg 2006;100:938-941.
51. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
52. Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008;198:1732-1741.
53. Khuroo MS, Khuroo MS. Hepatitis E virus. Curr Opin Infect Dis 2008;21:539-543.
54. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013;10:24-33.
55. Traore KA, Rouamba H, Nebie Y, Sanou M, Traore AS, Barro N, et al. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso. PLoS One 2012;7:e48125.
56. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 2013;56:62-64.